Osteobiologic B O N E G R A F T I N G S O L U T I O N S

Similar documents
Tissue cleaning and sterilization provide an additional level of safety

PRO-STIM Injectable Inductive Graft Containing DONATED HUMAN TISSUE

PRO-STIM Injectable Inductive Graft Containing DONATED HUMAN TISSUE

Human Tissue Intended for Transplantation Skin, corneas, sclera, bone, heart valves, blood vessels, pericardium, tendons, cartilage, fascia

Antibody-based HLA (Human Leucocyte Antigen ) tissue-typing technologies

CONDITIONS AND PROCEDURES FOR IMPORTATION AND EXPORTATION

Matrix HD. wound covering. Sterile, room temperature human dermis graft

Expert in biological products of human origin BLOOD PRODUCTS STABLE PRODUCTS STEM CELLS HUMAN TISSUES MOTHER S MILK

demineralized bone matrix with cancellous

Instructions for Use READY TO USE

The Biomechanics of ProLayer Acellular Dermal Matrix: suture retention strength

Liquid. This product is shipped with dry ice. Upon receipt, store it immediately at the temperature recommended below.

Cell Therapy Services Your Product. Our Passion.

ALLODERM SELECT ALLODERM SELECT RESTORE

FAQ ABOUT. 21CFR Part 1271 FDA REGULATION OF REPRODUCTIVE TISSUE LABS

Investor Presentation

FDA Perspective on Plasma Quality and GMPs

All quality control test results are reported on a lot specific Certificate of Analysis which is available at or upon request.

Processed from Donated Human Tissue by LifeCell Corporation for KCI USA, Inc.

B i o m a t e r i a l s E n g i n e e r i n g

Advancing the Science of Gamma Irradiation Continuous improvement in radiation sterilization

All quality control test results are reported on a lot specific Certificate of Analysis which is available at or upon request.

FDA Regulatory, Compliance and Policy Developments: 361 HCT/Ps

Sharon Tindle, MS, CQA (ASQ) QA Manager, BMT Tissue Services Mount Sinai Hospital, New York, NY. June 7, 2016

Each 7.0 cm x 7.0 cm dressing contains 140 to 260 mg of human fibrinogen and 130 International Units of human thrombin.

Understanding and Managing Bone Allografts A Guide for Perioperative Personnel. Practical guidance and tools

An Advancing Allografts Brief October Sterilization of Allografts. Advancing Allografts

Investor Presentation GUY COOK CEO

2015-Tissue Bank Processing

Luteinizing Hormone ELISA kit

All quality control test results are reported on a lot specific Certificate of Analysis which is available at or upon request.

Tissue Engineering For Regenerating Life. Cryopreserved Products. Tissue Corporation

APPLICATION FOR SITE INSPECTION Eye Bank Association of America

Quality Program: Supplies and Reagents

Affinity. A Paradigm Shift in Skeletal Reconstruction

Repliform. Tissue Regeneration Matrix. Instructions for Use. Distributed by:

Importing/Exporting Conventional HCT/Ps

SECTION H LABELING, PACKAGING, TRANSPORT AND DISTRIBUTION

Paul Ashford Executive Director ICCBBA

Excipient Albumin CSL Behring Human Serum Albumin

All donor screening, recovery and tissue processing is performed by a tissue bank registered with the Food and Drug Administration (FDA) and

Cellular Allogeneic Bone Graft

Special Issue. Mesoblast Limited

AAG PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

Tissue Products Catalogue

Aim. To provide basic knowledge on the processing, testing and issue of blood donations by NHSBT

Xeno-Free Systems for hesc & hipsc. Facilitating the shift from Stem Cell Research to Clinical Applications

YOUR PARTNER. In The Global Life Sciences Market. Value Plastics Fluid Management Components Biomaterial Delivery Devices Avalon Catheter Solutions

HANS BIOMED USA, Inc. 140 sylvan Ave Suite #4 Englewood Cliffs, NJ TEL FAX:

Australian Regulatory Guidelines for Biologicals

DuraGen Secure. Dural Regeneration Matrix

Bone Marrow Concentration. For customized cellular concentrations of platelet-rich plasma from bone marrow aspirate

BUILT TO CONCENTRATE. Magellan is an autologous concentration system that delivers concentrated platelets and cells at the point of care.

PicoKine ELISA. Catalog number: EK7102. For the quantitation of Human concentrations in Serum and Plasma

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

Subj: ESTABLISHMENT OF A HUMAN CELL, TISSUE, AND CELLULAR AND TISSUE-BASED PRODUCTS MANAGEMENT PROGRAM

Background. Background. Background. Background. Background 3/4/2013

More than surface deep

Irish Blood Transfusion Service Seirbhís Fuilaistriúcháin na héireann

PRINCIPLE SPECIMEN. REF (300 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

PAB PRINCIPLE. Kit Reorder # ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

The Effect of Mesenchymal Stem Cell Migration and Adhesion on Demineralized Bone Scaffolds under Vacuum Infusion Packaging Technology.

Specific Accreditation Guidance. Scope of accreditation - service descriptors for animal health

UDI Guidance Document for Medical Devices Containing HCT/P

FOR IMMEDIATE RELEASE

Quality Manual. Quality Manual. Vera Bioscience / Anu Life Sciences. April 2018

Precision Biospecimen Solutions: Paving the Way to Personalized Medicine

NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY:

Fentanyl (Human) ELISA Kit

Investor Presentation GUY COOK CEO

Asterand Bioscience Strategic Alliances

Inspections, Compliance, Enforcement, and Criminal Investigations

Update on the IVDR. Sue Spencer

TITLE: Implantable Tissue: Receipt, Storage, Use and Documentation

Project Proposal Ultrasound Mediated Tissue Engineering Project Team 21

MIIG INJECTABLE Graft The following languages are included in this packet:

CMC Considerations for Manufacturing of CAR T-Cell Product

HCT/P Deviations & Reporting. 13 th ANNUAL FDA & The Changing Paradigm for HCT/P Regulation February 13-15, 2017

Herpes Simplex 1 IgM (HSV1 IgM)

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)

Date. Albumin measurements are used in the diagnosis and treatment of numerous diseases primarily involving the liver and/or kidneys.

Cyfra 21-1 IRMA. Product information Information about other products is available at: Userś Manual DE52100

IGALC PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

APB PRINCIPLE SPECIMEN. REF (300 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

For In Vitro Diagnostic Use

AAT PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

Histocompatibility. Revised and effective July 14, Histocompatibility Standard 1 (HC S1)

Herpes Simplex 1 IgM (HSV1 IgM)

PEEK-OPTIMA HA ENHANCED. Advancing the Science of Fusion

M-TP PRINCIPLE REF ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

CONTRACT RESEARCH SERVICES

Specifically designed for abdominal wall repair STRUCTURAL

SmartPReP 2: The Gold Standard

HS-Code SS NACCS Unit 1 Unit 2 Description General WTO 1 Preferential Temp

Functional Assessment and Clinical Outcome

Best Practices for the Use of International Standards in Vaccine Testing Dianna Wilkinson

CAP Accreditation Checklists 2017 Edition

The Role of Standards in U.S. FDA Regulation of Cellular Therapy Products

CAP Accreditation Checklists 2016 Edition

Discover TruPRP. PRP the way you want it.

Transcription:

Osteobiologic BONE GRAFTING SOLUTIONS

The AlloSource Advantage Delivering Quality and Safety * Allografts labeled Sterile R are aseptically processed and packaged and then subjected to gamma irradiation. AlloSource has validated the sterility of its irradiated allografts in accordance with a technical standard published jointly by the American National Standards Institute (ANSI), the Association for the Advancement of Medical Instrumentation (AAMI), and the International Organization for Standardization (ISO). The FDA Standards Program recognizes the standard, ANSI/AAMI/ISO 11137, as a Consensus Standard. The Sterility Assurance Level (SAL) of tissue labeled Sterile is 10 6. AlloSource is one of the nation s largest nonprofit providers of bone, skin and soft tissue allografts for use in surgical procedures. The company maintains the highest standards in the recovery, processing and storage of human tissue while working to develop new therapeutic technologies. All tissue processed by AlloSource is derived from voluntary human tissue donation. AlloSource maintains a Quality Assurance Program in compliance with the following federal and state regulations and voluntary standards: FDA Human Cells, Tissues, and Cellular and Tissue-Based Products, 21 CFR Part 1271 FDA Human Tissue Intended for Transplantation, 21 CFR Part 1270 AATB Standards for Tissue Banking Clinical Laboratory Improvements Amendments (CLIA) Certification State of California Health and Safety Code State of Florida Statutes State of Maryland Code State of New York Public Health Law State of Oregon Registration Health Canada CTO Registration Certificate AlloSource is compliant with ISO 9001:2000, an internationally-recognized quality assurance standard, for the manufacture and distribution of tissue for transplant and the design, manufacture and distribution of tissue-based products. Precision at Every Step of the Process AlloSource has established multiple safeguards in our manufacturing process to assure allograft safety. These include: Tissue donation process initiated by a certified organ procurement organization (OPO) Rigorous donor screening in accordance with FDA regulations and standards published by the AATB, including verification of donor medical records and social history Rigid recovery procedures carried out by highly trained and qualified tissue recovery teams Extensive donor testing, including serological and microbiological testing, during recovery, processing and packaging Aseptic processing and packaging; microbial testing is performed on final products by a CLIA-certified lab to assure the safety of the allograft for transplantation in accordance with CLIA and AATB regulations Comprehensive post-processing review, including visual inspection of final allografts Post processing sterilization using low dose, low temperature irradiation when appropriate Allograft distribution after verification of labeling, sizing and expiration date Strict Donor Screening and Tissue Testing AlloSource requires a comprehensive donor physical assessment and a complete medical and social history to identify and eliminate donors that are at risk of being carriers of certain viruses and diseases. Donor acceptance criteria are based on FDA regulations and AATB Standards as well as additional standards set by the AlloSource Medical Advisory Board. Donors must test negative or non-reactive in the following assays: Antibody to Hepatitis C (HCV) Antibody to Human Immunodeficiency Virus 1 & 2 (HIV 1 & 2) Antibody to Human T-Cell Lymphotropic Virus Type I & II (HTLV I & II) Hepatitis B Core IgG/IgM Antibody (HBcAb) Hepatitis B Surface Antigen (HBsAg) Hepatitis C Virus (HCV NAT) Human Immunodeficiency Virus Type 1 (HIV-1 NAT) Rapid Plasma Reagin or Serologic Test for Syphilis (RPR or STS) All tests are conducted using FDA-approved test kits.

AlloSponge and AlloFlex AlloFlex Versatile Bone Grafting Materials that Support Matrix Formation AlloSponge supports the creation of a structural matrix for bone formation while encouraging cellular ingrowth. Its unique sponge-like structure is flexible enough to be compressed to fill a challenging space and resilient enough to expand to its original size without compromising its strength. AlloSponge is valued by surgeons for its versatile benefits, including: Compressible and flexible enough to fill bone defects of nearly any shape or size Capable of absorbing fluids like blood and serum Can be used as adjunct in spine surgery as a PEEK cage filler, in multi-level fusion or to fill a bone or tumor void Excellent delivery tissue for biologic agents like bone marrow aspirate, synthetic bone morphogenic proteins, DBM gels and other bone-forming biologic concentrations AlloFlex strips are flexible and can contour to any anatomical curvature an optimal solution for many craniofacial surgery applications as a bone defect wrap. AlloFlex 60715510 AlloFlex Small 10 x 50 x 2 4 mm 60715515 AlloFlex Medium 15 x 50 x 2 4 mm 60715520 AlloFlex Large 20 x 50 x 2 4 mm 60715750 AlloFlex Ex-Large 50 x 70 x 2 4 mm AlloSponge Block AlloSponge Blocks 60515008 AlloSponge Block (8 mm) 3 60515010 AlloSponge Block (10 mm) 3 60515012 AlloSponge Block (12 mm) 3 60515014 AlloSponge Block (14 mm) 3 AlloSponge Strip AlloSponge Filler 60815002 AlloSponge Filler 2.5 cc 60815005 AlloSponge Filler 5 cc 60815010 AlloSponge Filler 10 cc AlloSponge Strips 60615102 AlloSponge Strip 10 x 20 x 3 6 mm 60615154 AlloSponge Strip 15 x 40 x 3 6 mm 60615205 AlloSponge Strip 20 x 50 x 3 6 mm

AlloFuse and AlloFuse Plus Easy-to-Use Bone Growth Solutions for Almost any Application AlloFuse products are formulated to help stimulate natural bone formation processes in which mesenchymal cells differentiate into bone-forming cells. They offer a high level of DBM content provided in a reverse-phase polaxymer carrier for effective performance. Used alone or in combination as a bone graft extender, AlloFuse and AlloFuse Plus provide: Proven osteoinductivity: Each lot of DBM is tested for its ability to stimulate new bone formation Superior handling: Available as a paste, putty or gel, AlloFuse is highly malleable and easy to mold and pack into any defect Excellent graft containment: AlloFuse thickens at body temperature and resists irrigation to minimize the likelihood of migration from the surgical site Ready-to-use application: AlloFuse can be used without thawing, mixing or other preparation, no refrigeration is needed AlloFuse DBM Gel AlloFuse DBM Gel 90138001 1 cc Injectable Gel 90138005 5 cc Injectable Gel 90138010 10 cc Injectable Gel AlloFuse DBM Putty 90038001 1 cc Putty 90038002 2.5 cc Putty 90038005 5 cc Putty 90038010 10 cc Putty AlloFuse Plus DBM Paste and Putty 90238001 1 cc Paste 90238003 3 cc Paste 90238008 8 cc Paste 9033800 5 cc Putty 90338010 10 cc Putty AlloFuse DBM Putty To order call: Customer Service 1 800 557 3587

AlloGro, Cancellous Chips, AlloPac, and CanPac Products for Effective Bone Healing AlloGro DBM is effective in procedures where augmented bone healing is desired, including: Bone voids and defects Structural allograft implants Non-unions and delayed unions Spinal fusion Fractures Each lot of AlloGro DBM is tested for its osteoinductive potential and only allograft which demonstrates osteoinductivity is made available for distribution. Other bone healing products from AlloSource include: Cancellous Chips AlloPac CanPac AlloPac and CanPac undergo limited processing so more of the blood and lipid products remain with the bone. AlloPac is cortical-cancellous bone and CanPac is cancellous bone. AlloPac AlloGro AlloGro Demineralized Bone Matrix 34910925.25 cc 35010950.50 cc 35110001 1 cc 35210003 3 cc 10111010 10 cc 10111015 15 cc 10111030 30 cc Cancellous Chips Freeze-dried Frozen 27615005 5 cc (approximately 4 9.5 mm) 27615015 27617015 15 cc (approximately 4 9.5 mm) 27615030 27617030 30 cc (approximately 4 9.5 mm) 27615060 60 cc (approximately 4 9.5 mm) 27517050 50 cc (approximately 1 9 mm) 27517090 90 cc (approximately 1 9 mm) 27615090 90 cc (approximately 4 9.5 mm) AlloPac (cortical-cancellous chips) 10216025 25 cc Non-purged, aseptic 10216050 50 cc Non-purged, aseptic 10216100 100 cc Non-purged, aseptic 10317025 25 cc Non-purged, irradiated 10317050 50 cc Non-purged, irradiated 10317100 100 cc Non-purged, irradiated CanPac (cancellous chips) 24416025 25 cc Non-purged, aseptic 24416050 50 cc Non-purged, aseptic 24416100 100 cc Non-purged, aseptic 24417025 25 cc Non-purged, irradiated 24417050 50 cc Non-purged, irradiated 24417100 100 cc Non-purged, irradiated Cancellous Chips

AlloSource 6278 South Troy Circle Centennial, Colorado 80111 720 873 0213 Toll Free 800 557 3587 Fax 720 873 0212 AlloSource is registered with the U.S. Food and Drug Administration (FDA) and accredited by the American Association of Tissue Banks (AATB). AlloSource is compliant with the AATB Standards for tissue banking and with all applicable state regulations and voluntary guidelines as required and is compliant with the ISO 9001:2000 standard. We support efforts to promote organ and tissue donation through our collaboration with Donate Life America. www.allosource.org M1S0717.00 06/2009